A Prospective, Multicenter, Randomized, Controlled, Non-Inferiority Clinical Trial to Evaluate the Efficacy and Safety of Absorbable Bone Wax in Pediatric Patients Undergoing Bone Hemostasis.

INTERVENTION: Experimental Group:Intraoperative hemostasis of bone wounds, using absorbable bone wa Xfor children.;Control Group:Intraoperative hemostasis of bone wounds, using BoneWax.; CONDITION: Pediatric patients requiring hemostasis for bone surfaces PRIMARY OUTCOME: Hemostasis efficacy within 3 minutes; SECONDARY OUTCOME: Adverse events and serious adverse events (AEs and SAEs);Bone healing rate;Device defect;Device performance evaluation;Amount of bone wa Xused;Bone wa Xextrusion rate;Complications: granuloma, infection, postoperative secondary bleeding or hematoma, subcutaneous effusion, poor incision healing, etc.;Number of bone wa Xapplications;Incision Grade I healing rate;Average effective hemostasis time; INCLUSION CRITERIA: 1. Aged between 2 and 18 years, regardless of gender. 2. Pediatric patients with bone wounds requiring hemostasis. 3. Sign the informed consent form as required.